Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
NDYN>>>Up 22% thin L2..
NDYN up 22% @0.10 bottom reversal. Expecting major contract news on Thursday. Thin L2
Here you go....
Positron Recieves Radioactive Materials License from Nuclear
Share Business ExchangeTwitterFacebook| Email | Print | A A A
Positron Recieves Radioactive Materials License from Nuclear Regulatory
Commission
Business Wire
INDIANAPOLIS -- March 01, 2010
Positron Corporation (OTCBB:POSC) a molecular imaging solutions company
focused on Nuclear Cardiology, announced today that the Nuclear Regulatory
Commission has licensed the Positron facility in Fishers, Indiana to handle
radioactive material. Positron Corporation and staff demonstrated the
necessary expertise and protocol to receive this license. A radioactive
material handling license allows Positron to test equipment and develop new
technologies, including pharmaceuticals. “A radioactive material license
directly benefits our current product line and increases our ability to
deliver new technologies,” stated John A. Zehner, Positron Corporation, COO
and Radiation Safety Officer. “The ability to handle radioactive material will
enhance our sales efforts, allow new revenue streams, as well as, offer new
opportunities to partner with pharmaceutical companies, Government agencies,
inventors and universities.”
About Positron: Positron founded in 1983, is a molecular imaging company
focused on Nuclear Cardiology. Positron utilizes its proprietary product line
to provide unique solutions to the Nuclear Medicine community ranging from
imaging systems to radiopharmaceutical distribution. Positron products
include: the Attrius™, a PET imaging device; the Pulse®, a SPECT imaging
device; the Nuclear Pharm-Assist®, an automated radiopharmaceutical
distribution device; and the Tech-Assist™, a radiopharmaceutical injection
shield. Positron is headquartered in Indianapolis, Indiana. More information
about Positron is available at www.positron.com.
Forward Looking Statements: Statements in this document contain certain
forward-looking statements within the meaning of Section 27A of the Securities
Act of 1933 and the Securities Exchange Act of 1934, as amended. These
statements are based on many assumptions and estimates and are not guarantees
of future performance and may involve known and unknown risks, uncertainties
and other factors which may cause the actual results, performance or
achievements of Positron Corporation to be materially different from future
results, performance or achievements expressed or implied by such
forward-looking statements. Our actual results may differ materially from the
results anticipated in these forward-looking statements due to a variety of
factors, including, without limitation those set forth as "Risk Factors" in
our filings with the Securities and Exchange Commission.
For further information please contact Positron Corporation at (317) 576-0183.
Contact:
Positron Corporation
John Zehner
(317) 576-0183
Last Updated: March 1, 2010 13:46 EST
Buys 1.060Mil Sells:386K as of 3.44pm today. This is a pressure cooker....
Yes...Back to green
Yeahhh...We did it!@
Got to love them MM games..SHO us...They are going to pay dearly on this one because the rally is going to go for a LONG time
Need to close above 0.12 today...
Alrady on the POSC party boat..
We are going to PARTY Next Week!!!
Off to the races...We are going to ROCK and ROLL next week. Can't wait
Blastoff!!!It's SSWC and she is going to win...If she hits .005 today I surely am going to have a long Tequila on SSWC tonight!
Yep...There she goes! Love this...More to come next week. Hold onto your pants fellas....<lol>
Rainmaker is the man!!!Thank you for all of your great DD!!!
LOVE THIS STOCK!!! Take Them 4's out today////
Read my message again. This is exactly what I wrote...
This may have something to do with why they are ramping up the indiana site:
Positron Recieves Radioactive Materials License from Nuclear
Share Business ExchangeTwitterFacebook| Email | Print | A A A
Positron Recieves Radioactive Materials License from Nuclear Regulatory
Commission
Business Wire
INDIANAPOLIS -- March 01, 2010
Positron Corporation (OTCBB:POSC) a molecular imaging solutions company
focused on Nuclear Cardiology, announced today that the Nuclear Regulatory
Commission has licensed the Positron facility in Fishers, Indiana to handle
radioactive material. Positron Corporation and staff demonstrated the
necessary expertise and protocol to receive this license. A radioactive
material handling license allows Positron to test equipment and develop new
technologies, including pharmaceuticals. “A radioactive material license
directly benefits our current product line and increases our ability to
deliver new technologies,” stated John A. Zehner, Positron Corporation, COO
and Radiation Safety Officer. “The ability to handle radioactive material will
enhance our sales efforts, allow new revenue streams, as well as, offer new
opportunities to partner with pharmaceutical companies, Government agencies,
inventors and universities.”
About Positron: Positron founded in 1983, is a molecular imaging company
focused on Nuclear Cardiology. Positron utilizes its proprietary product line
to provide unique solutions to the Nuclear Medicine community ranging from
imaging systems to radiopharmaceutical distribution. Positron products
include: the Attrius™, a PET imaging device; the Pulse®, a SPECT imaging
device; the Nuclear Pharm-Assist®, an automated radiopharmaceutical
distribution device; and the Tech-Assist™, a radiopharmaceutical injection
shield. Positron is headquartered in Indianapolis, Indiana. More information
about Positron is available at www.positron.com.
Forward Looking Statements: Statements in this document contain certain
forward-looking statements within the meaning of Section 27A of the Securities
Act of 1933 and the Securities Exchange Act of 1934, as amended. These
statements are based on many assumptions and estimates and are not guarantees
of future performance and may involve known and unknown risks, uncertainties
and other factors which may cause the actual results, performance or
achievements of Positron Corporation to be materially different from future
results, performance or achievements expressed or implied by such
forward-looking statements. Our actual results may differ materially from the
results anticipated in these forward-looking statements due to a variety of
factors, including, without limitation those set forth as "Risk Factors" in
our filings with the Securities and Exchange Commission.
For further information please contact Positron Corporation at (317) 576-0183.
Contact:
Positron Corporation
John Zehner
(317) 576-0183
Last Updated: March 1, 2010 13:46 EST
The Altruis PET scanner is manufactured by Neusoft in China through the JV. The Nuclear Pharm Assist is manufactured here in in the US in Indiana through the accusition of Dose Shield Corp (Acquisitions was completed last year July/August 2009). Positron is ready to launch the Cardio-Assist Device - a"virtual compound pharmacy" in the physicians offices. The Cardio Assist will also be manufactured at their Indiana Site.
Kenneth P Glynn Patents:
1. 20100109294 Tactical breaching demonstration trailer 05-06-2010
2. 20100072895 Non combustible, tactical flash device - to a non-combustible tactical flash device includes a non-spherical hollow main housing having a plurality of 03-25-2010
3. 20090297267 Recycled tire paver blocks - with hidden interconnectors are cast blocks composed at least of a binder and rubber 12-03-2009
4. 20090236383 Tactical carrying pack - for back-supported transport of a payload 09-24-2009
5. 20090081135 Iodine-based oral antibacterial treatment methodology 03-26-2009
6. 20090024421 Life rewardance insurance system and methodology 01-22-2009
7. 20090007905 Spacer/holding chamber for pressurized metered dose inhaler 01-08-2009
8. 20080303282 Water cycling system with compressor motive force and with turbine electric power generator 12-11-2008
9. 20080262934 Freshly prepared food delivery methodology 10-23-2008
10. 20080239077 Motor vehicle accident recording system - for portable installation in a conventional motor vehicle includes: a 10-02-2008
11. 20080238101 Gas production well secondary purpose turbine electric power generator system 10-02-2008
12. 20080238099 Water supply tunnel secondary purpose turbine electric power generator system 10-02-2008
13. 20080235784 Gateway log in system with user friendly combination lock 09-25-2008
14. 20080230669 Tile cutter attachable propane torch tank caddy 09-25-2008
15. 20080229397 Website log in system with user friendly combination lock 09-18-2008
16. 20080210228 Monodose nasal sprayer - The sprayer device utilizes a friction held piston that fires automatically upon full depression of the firing cap 09-04-2008
17. 20080199833 Automatic intuitive painting methodology 08-21-2008
He is a very busy and resourceful man...Very exciting here!!!
Check out a new product that Positron just recently added in addition to 4 products: Alltruis, Nuclear Pharm Assist, Tech Assist, the Nuclear CDC Spect scan and now added the new Nuclear Cardio Assist Here is the link to the product web page:
http://www.positron.com/cardio_assist.html
Once again if the partnership agreement is tied to specific revenue/sales milestones per Quarter that is in the $7.5Mil-10Mil range for a total projection of $30-40Mil per year and $90-120Mil over a 3year period then this stock will go to $1.20+ once the news hits.
However if the PR is vague about the partnership and just announces the Multi Billion Dollar company and the scope without mentioning hard revenue/sales milestones then I foresee <$1.00
This is just for one of the partnerships if we add the potential of everyhing together that is going to happen here over the next 3months then I am very bullishly expecting >$1.00+ and a uplisting to the NASDAQ over the next 18months will definitely be in the works.
POSC will have to get their PR act together though.....
If POSC go to 0.05 you can bet your bottom dollar I am buying another 100K $$$ (not shares)....I am that confident that this company is going to skyrocket here shortly. It will have a initial 300-400% gain from the 0.05-06 levels and then another 300-400 gains from the 0.20-30 cents levels when the REALLY big news comes in over the next 4weeks. We EXPECT at least 3-4 PR's that is going to move this stock up starting as soon as perhaps this Friday or early next week. There is a lot of information that they have not PR'ed yet for one reason or another.
RNWF>>MOASS upgrade>>>L2 thinning...Let's make the MM's eat dirt for shorting 100Mil+ shares
Oh LOL....I know that one..My bad..Thanks
That is new for me..What is MOASS?
RNWF>>UP 0.0027
RNWF>>>Up she goes>>Thin L2
RNWF>>>Up she goes
RNWF>>>Uo 40% this morning>Target .005
RNWF>>>Up 35% this morning..Short imminent short squeeze play..
I know this is a old PR but a lot of us is seeing this for the first time and it's important for ALL to understand all of the potential that POSC has got going on....The link of POSC with Naviscan is new on this board. I have not see anyone posting ANY information here regarding NAVISCAN before....Naviscan was founded by Dr Irvine Weinberg and Mr Weinberg is considered a pioneer in Diagnostic Mammogram Imaging. POSC and Naviscan filed for for several patents together...Very important for future revenue streams
Positron Subsidiary Files Patent Applications for Proprietary Radiation Detection Technologies To Be Used in PET Scanners and Homeland Security Devices
Friday March 2, 4:01 pm ET 2008
HOUSTON--(BUSINESS WIRE)--Positron Corporation (OTCBB: POSC - News; the Company), a developer and manufacturer of Positron Emission Tomography (PET) medical devices, announced today that through its subsidiary developed intellectual property in the field of solid state photo detection and its applications. The Company has four patents pending covering the design and construction of medical diagnostic molecular imaging scanners and radiation detection scanners for homeland security with its new class of solid state photodetectors. The compact, low-cost photodetectors have increased sensitivity that can detect a single quantum of light and may significantly reduce the cost of future PET scanners while improving spatial resolution and portability. Solid state photodetectors are the key component in the development of compact organ-specific PET scanners and effective radiation detection devices for monitoring of radiation proliferation by parties unfriendly to national security interests. The Company's research and development projects were conducted at facilities across North America with the participation of a team of collaborating scientists directed by Dr. Irving Weinberg. Dr. Weinberg is Chief Scientific Officer of the Positron research and development subsidiary.
The miniaturization afforded with this solid state photodetector technology is designed as the evolution of positron emission technologies that will enable the development of the next generation of efficient and economical full-body scanning devices, integrated PET/MRI scanners and the development of a single-use organ specific low-cost camera that can be disposed of after a single medical procedure.
The homeland security application is based on the ability to build a small transportable device using the compact solid state technology to detect very low levels of radiation emitted by illicit radioactive materials from a distance.
Dr. Irving Weinberg stated: "The solid state photodetectors will allow us to build radiation detection systems with high sensitivity. In new medical diagnostic nuclear imaging systems it will allow reduced patient radiation exposure because of lower radiopharmaceutical dosage, while in the homeland security application, a small radiation event can be detected from a substantial distance".
About Positron:
Positron Corporation designs, manufactures, markets and supports advanced medical imaging devices utilizing positron emission tomography (PET) technology. Positron Corporation incorporates patented and proprietary software and hardware technology for the diagnosis and treatment of patients in the areas of cardiology, oncology and neurology. Positron Corporation offers unique combination of low cost technology and disease specific software solutions differentiating themselves from all other medical device manufacturers. Positron's PET systems are in use at leading medical facilities throughout North America and in select International markets. Additional information may be found at www.positron.com.
Positron Corporation ("Positron" "POSC") is the first name in positron emission tomography (PET). Positron designs, markets, services and develops software solutions for their advanced medical imaging devices utilizing PET technology. Positron has the most advanced technology for Cardiology PET imaging and is well positioned to take advantage of its existing cardiac brand with innovative, cost-effective medical devices in conjunction with a complete disease management software solution.
PET differs from other imaging technologies by measuring biological processes of organs and tissues and produces functional images for the diagnosis and treatment of patients in the areas of cardiology, oncology and neurology. Positron offers a unique combination of low cost technology and disease specific software solutions differentiating themselves from all other medical device manufacturers. Positron has an experienced clinical management team with more than a decade of clinical expertise in many disciplines within the Cardiac PET industry.
In 2005 Positron formed a joint venture with Neusoft Medical Systems in Shenyang, China called Neusoft-Positron Medical Systems Co., Ltd (NPMS). NPMS will manufacture all of Positron’s PET and PET/CT systems, dramatically lowering manufacturing costs and allowing Positron to be much more competitive in the global marketplace. This efficiency enables Positron to market and deliver the lowest priced, high quality PET and PET/CT devices in the industry.
In 2006/2007 Positron acquired Imaging PET Technologies (IPT), parent corporation of IS2 Medical Systems. IS2 Medical Systems develops builds and services Nuclear Medicine Gamma Cameras (SPECT) offering clinical users the highest resolution in the industry, the most robust feature set and the highest levels of performance and reliability, all at the best prices. A scintillation, or gamma camera, is a diagnostic medical imaging system that is part of a family of systems commonly referred to as .body scanners. Gamma cameras are used in the diagnosis of heart disease, cancers and a variety of other disorders. A mechanical frame (a gantry) rotates an electronic detector head around a patient in order to take a series of clinical images of inside of the body. The scientific team responsible for the design and continued innovation of the company’s world-class cameras comprise more than 125 years of expertise in nuclear medicine physics, mathematics and engineering. The Company is ISO certified and meets related medical device, safety and regulatory requirements, including USA FDA and Health Canada approval, and has a CE Mark necessary for European distribution.
IPT's R&D subsidiary, Quantum Molecular Technologies (QMT) aims to become a significant player by revolutionizing molecular imaging. QMT’s current research is focused on the design and manufacturing of new solid state detectors and data acquisition electronics. This solid state detector will have direct impact on all current imagining modalities as well as new markets including homeland security and high energy physics technologies.
With the acquisition of IPT and its joint venture with Neusoft Medical, Positron is able to offer SPECT, SPECT/CT, PET and PET/CT products in the molecular imaging field and positioned to be at the cutting-edge of the next frontier in molecular imaging. Positron’s plan of action is to take advantage of integration and synergies between companies to increase sales and marketing, product service, clinical applications and R&D.
As part of its full solution, Positron is developing disease-specific software for end users. Positron’s software will be ready to market with the release of its PET camera for NPMS. During 2007 Positron intends to debut its new scanner technology and software solutions package at the 54th annual meeting of the Society of Nuclear Medicine in Washington D.C. and to the Nuclear Cardiology community at the 12th annual meeting of the American Society of Nuclear Cardiology in San Diego, California
Patent filing: http://www.freshpatents.com/-dt20090430ptan20090108217.php?type=description
Founders of the Altruis PET Scanner
Dr. Irvine Weinberg…Is the Chief R&D of Positron Corp…Owns it’s own company called, Naviscan PET Systems, Inc.
11180 Roselle St.
San Diego, CA, 92121, USA.
Dr Irvin Weinberg is renowned for the development of PEM (PET Mammography) technology for detecting breast cancer.
The IMAGIN diagnostics Centers (IMGM) has listed as it's affiliates:
http://www.imagincentres.com/Affiliates.html
Naviscan Pet Systems
Positron
Quantum Molecular Technologies
IS2/IPT
Naviscan PET systems is Dr Irvin Weinberg's company (he is the founder and inventor of the PEM (only Positron Emission Mammography on the market)......This is a private company and boast installed PEM's
http://www.naviscan.com/
They (the management team of IMGM anD POsc) may not have the best track record in the business but they sure seem to have a very good market cornered here..... Dr Irvine Weinber affiliation is definitely giving them a big boost as far as creditability....
I like that..Very poetic..Just what we need to lighten the spirit. I will bless this stock with good ESP and we shall see news here very soon.
I can but then you will just delete it<lol>
It is still relevant...It's a 3-4year 2007-2011 business plan which they are executing against.
Take a look at my post 31153 on the Etls board and this may give you more confidence! Also take a look at the charts and sho list in the ihub for etls. This will give you fairly good indication how rnwf is going to trade over the next week or so. Eom.
Links to PR's
SPARKS, NV, USA - Green Fuels, Ltd of Stonehouse, England, have acquired the assets of Renewal Fuels, Inc and Renewal Biodiesel, Inc to create Green Fuels America, Inc with headquarters in Sparks, Nevada.
http://www.biofpr.com/details/news/247221/Acquisition_by_Green_Fuels.html
Websites to search for Renewal Fuels, INC SOS listing:
http://corp.delaware.gov/ >>> select link Entity Search>>>key "renewal fuels, inc.">>>Select second company on the list. You will have to pay $20 to see all of the filings.
Thanks
Michael D' Onofrio is man with many stakes in different companies somehow all interlink. Check this out:
1. VP of M&A of Tital Global Holdings (TTGL)
2. Partner at Treasure Coast Capital that happens to do a lot of MA funding for TTGL. Specialize in MA Fuels & Distribution.
3. NewGen (NWGN) Founder and CEO
4. CEO/Founder of Refuel America
Have a history of doing MA for private investors in Pharma/medical devices/ imaging. Mark Uram have a background in M&A's in Pharma with Schering Plough, Merck and is now working for a small biotech firm in PA. I bet these two know each other very well.
Bryan Chance, David Marks and Crivello LLC is all major shareholders and on the boards of:
TTGL, RNWF, NWGN, ETLS. Not so far fetched to think that some of the TTGL subsidiaries in fuels are being prepared to go public through a number of these shells.
Did you ask him whether they had any intentions for the shell?
CEO of Renewal Biodiesel Solitions:
Biodiesel Solutions Inc.
Media Contact:
Greg Springer
(775) 358 6400 x102
greg@biodieselsolutions.com
is now also the CEO of GreenFuels America (the new company)
Media Contact:
Greg Springer, P.E.
VP and GM
Green Fuels America
greg@greenfuelsamerica.com
(866) 996 6130
Green Fuels America elects E2 ECO Energy to be Sales Representative of Commercial Biodiesel Processor Equipment in Columbia
Somebody may want to contact greg and find out what is REALLY going on with this shell of RNWF....